Further studies have demonstrated that METTL14 suppresses the expression of NEAT1_1 in an m6A-dependent manner via YTHDF2-dependent RNA degradation, thereby inhibiting the progression and metastasis of RCC. The gene discussed is METTL14; the disease is renal cell adenocarcinoma.